News and Announcements
FerriScan Contracted for Two New Clinical Trials
- Published October 23, 2012 2:18AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Resonance Health has executed two multi-year contracts with a pharmaceutical company to provide FerriScan services, for an undisclosed sum.
One contract will involve Resonance Health working with up to 15 MRI facilities that will image patients participating in the clinical trial. Resonance Health will provide FerriScan image analysis services to measure liver iron concentration and a cardiac iron assessment for these patients. Resonance Health recently gained regulatory approval for the measurement of a parameter called cardiac T2* which provides an indirect assessment of cardiac iron overload.
——–
To view the full article, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
